Specifically in breast cancer, the oncogenic transcription factor c-Myc reprograms the cellular metabolism towards aerobic glycolysis by directly transactivating a number of glycolytic genes, including GLUT1, HK2, PDK1, and LDHA [33,34,35]. Here, MYC is linked to breast carcinoma.